Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8Neoplasms 4Pain, Postoperative 2Hemangioma, Capillary 2Carcinoma, Hepatocellular 2Anxiety Disorders 2Weight Loss 1Vomiting 1Urinary Incontinence, Stress 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Shoulder Pain 1SCLC, Limited Stage 1Respiratory Aspiration 1Psychomotor Agitation 1Prostatic Neoplasms 1Premature Birth 1Polycystic Ovary Syndrome 1Pediatric Obesity 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Cysts 1Obesity 1Neuromuscular Diseases 1Neuroblastoma 1Nasopharyngeal Carcinoma 1Myofibroma 1Myelodysplastic Syndromes 1Myasthenia Gravis 1Multiple Myeloma 1

Interventions

telitacicept 3fludarabine 3Prednisone 3Data Collection 3Cyclophosphamide 3Specimen Handling 2Nivolumab 2Blood Specimen Collection 2Antilymphocyte Serum 2thymoglobulin 1remdesivir 1prednylidene 1human papillomavirus vaccine, L1 type 16, 18 1deltacortene 1carmustine, poliferprosan 20 drug combination 1cabozantinib 1apremilast 1Watchful Waiting 1Vitamin D 1Valsartan 1Telemedicine 1Surveys and Questionnaires 1Standard of Care 1Pyridostigmine Bromide 1Practice Guidelines as Topic 1Population Groups 1Platinum Compounds 1Plasma Exchange 1Phlebotomy 1Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Autoimmune Diseases × Population Groups × Clear all
NCT06827587 2025-02-14

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

First Affiliated Hospital of Wenzhou Medical University

Phase NA Not yet recruiting
60 enrolled

Autoimmune Diseases, Myasthenia Gravis, Neuromuscular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡